Gastroenterology

Unlocking precision medicine for inflammatory bowel disease

The prevalence of inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn's disease (CD), is rapidly increasing worldwide, affecting an estimated 6.8 million people. This surge brings significant ...

Oncology & Cancer

Mini-colons advance colorectal cancer research

In a breakthrough for cancer research, scientists at EPFL have created lab-grown mini-colons that can accurately mimic the development of colorectal tumors, offering a powerful new tool for studying and testing treatments ...

Medical research

Host genome controls skin microbiota and inflammation

Numerous recent studies linked gut microbiota with various diseases such as obesity or diabetes. Little is known, however, on how gut and skin microbiota composition is controlled. In a recent study published in the journal ...

Oncology & Cancer

Prostate cancer tumors' aggressiveness may be inherently fixed

A new study of prostate cancer suggests that a tumor's aggressiveness is inherently fixed at the time of its appearance, although diet, lifestyle and environmental factors may trigger progression of the disease in low-level ...

Diseases, Conditions, Syndromes

Pesticides increase the risk of schistosomiasis, a tropical disease

Schistosomiasis is a severe infectious disease caused by parasitic worms. As an intermediate host, freshwater snails play a central role in the life cycle of the parasite. In a recent study published in the journal Scientific ...

Autism spectrum disorders

Dramatic rise in autism prevalence parallels research explosion

Autism Speaks Chief Science Officer Geraldine Dawson, Ph.D. describes how the dramatic progress in autism research has paralleled increased recognition of autism's prevalence and financial impact in the December issue of ...

page 11 from 16